# Statins for Acutely Injured Lungs From Sepsis

> **NCT00979121** · PHASE3 · TERMINATED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 745 (actual)

## Conditions studied

- Sepsis
- Acute Lung Injury

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00979121
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 745 (ACTUAL)
- **Why stopped:** stopped for futility
- **Last updated:** 2016-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979121, "Statins for Acutely Injured Lungs From Sepsis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00979121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*